Naturhouse Health S.A risk profile
30 Normal where most of the sector sits
Measured 1 September 2026 from 2NH's filed statements. Recomputed nightly.
30 (Normal), driven by Operating pressure at 39, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 36 | Normal | Stable | One-year price volatility — 29.2% |
| Operating pressure | 39 | Normal | Easing | Costs outgrowing revenue — -1.6 percentage points |
| Cash conversion | 22 | Normal | Stable | Cash conversion — 1.20x |
| Leverage and coverage | 9 | Contained | Worsening | Current ratio — 1.65x |
| Competitive position | 33 | Normal | Stable | Revenue-growth gap against peers — -13.6 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Consumer Defensive companies with a risk reading
Walmart Inc 43Costco Wholesale Corp 40Coca-Cola Company 30Procter & Gamble Company 34Philip Morris International Inc 24Nestle S.A. 45Nestlé S.A 45L'Oréal S.A. 32PepsiCo Inc 43Anheuser-Busch InBev SA/NV 35Unilever plc 42Unilever PLC 42
Financials, valuation and price history for Naturhouse Health S.A